Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E M Sorkin

Showing results (1-10 of 61) with videos related to

Pageof 7
Sort By:
Drugs|November 1, 1989
Azelastine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potentialD McTavish, E M Sorkin
Drugs|April 1, 1987
Esmolol. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacyP Benfield, E M Sorkin
Drugs|July 1, 1989
Verapamil. An updated review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertensionD McTavish, E M Sorkin
Drugs|July 1, 1991
Pravastatin. A review of its pharmacological properties and therapeutic potential in hypercholesterolaemiaD McTavish, E M Sorkin
Drugs|June 1, 1986
Indoramin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in hypertension and related vascular, cardiovascular and airway diseasesB Holmes, E M Sorkin
Drugs|October 1, 1993
Sotalol. An updated review of its pharmacological properties and therapeutic use in cardiac arrhythmiasA Fitton, E M Sorkin
Drugs|October 1, 1994
Abciximab (c7E3 Fab). A review of its pharmacology and therapeutic potential in ischaemic heart diseaseD Faulds, E M Sorkin
Drugs|December 1, 1989
Epoetin (recombinant human erythropoietin). A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in anaemia and the stimulation of erythropoiesisD Faulds, E M Sorkin
Drugs & Aging|January 1, 1992
Ocular carteolol. A review of its pharmacological properties, and therapeutic use in glaucoma and ocular hypertensionP Chrisp, E M Sorkin
Drugs|February 1, 1986
Ocular sodium cromoglycate. An overview of its therapeutic efficacy in allergic eye diseaseE M Sorkin, A Ward
Pageof 7

Showing results (1-10 of 61) with videos related to

Sort By:
Pageof 7
Drugs|November 1, 1989
Azelastine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potentialD McTavish, E M Sorkin
Drugs|April 1, 1987
Esmolol. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacyP Benfield, E M Sorkin
Drugs|July 1, 1989
Verapamil. An updated review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertensionD McTavish, E M Sorkin
Drugs|July 1, 1991
Pravastatin. A review of its pharmacological properties and therapeutic potential in hypercholesterolaemiaD McTavish, E M Sorkin
Drugs|June 1, 1986
Indoramin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in hypertension and related vascular, cardiovascular and airway diseasesB Holmes, E M Sorkin
Drugs|October 1, 1993
Sotalol. An updated review of its pharmacological properties and therapeutic use in cardiac arrhythmiasA Fitton, E M Sorkin
Drugs|October 1, 1994
Abciximab (c7E3 Fab). A review of its pharmacology and therapeutic potential in ischaemic heart diseaseD Faulds, E M Sorkin
Drugs|December 1, 1989
Epoetin (recombinant human erythropoietin). A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in anaemia and the stimulation of erythropoiesisD Faulds, E M Sorkin
Drugs & Aging|January 1, 1992
Ocular carteolol. A review of its pharmacological properties, and therapeutic use in glaucoma and ocular hypertensionP Chrisp, E M Sorkin
Drugs|February 1, 1986
Ocular sodium cromoglycate. An overview of its therapeutic efficacy in allergic eye diseaseE M Sorkin, A Ward
Pageof 7